These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 8281344)

  • 1. Plasma kallikrein amidolytic activity in patients with urticaria.
    Monteseirín J; Bobadilla P; Galindo PA; Delgado J; Palma JL; Llamas E; Conde J
    J Investig Allergol Clin Immunol; 1993; 3(3):142-5. PubMed ID: 8281344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma kallikrein amidolytic activity in bronchial asthma.
    Monteseirín J; Galindo PA; Pérez J; Bobadilla P; Conde J
    Allergol Immunopathol (Madr); 1992; 20(5):211-4. PubMed ID: 1292330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protease inhibitors in plasma of patients with chronic urticaria.
    Doeglas HM; Bleumink E
    Arch Dermatol; 1975 Aug; 111(8):979-85. PubMed ID: 60915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Benzoyl-kallikrein: kallikrein activity and kinin generation in plasma].
    Müller H; Stürzebecher J; Markwardt F
    Biomed Biochim Acta; 1986; 45(7):941-4. PubMed ID: 3641630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased plasma kallikrein 5 concentrations in patients with chronic spontaneous urticaria.
    Grzanka A; Damasiewicz-Bodzek A; Szumska M; Kasperska-Zajac A
    J Biol Regul Homeost Agents; 2017; 31(2):407-411. PubMed ID: 28685545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme activation and inhibition induced by cold provocation in a patient with cold urticaria.
    Martens PM; Berrens L
    Acta Derm Venereol; 1975; 55(2):121-5. PubMed ID: 48315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinase-9: a novel biomarker for monitoring disease activity in patients with chronic urticaria patients?
    Altrichter S; Boodstein N; Maurer M
    Allergy; 2009 Apr; 64(4):652-6. PubMed ID: 19317840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Specificity of the determination of urinary kallikrein activity using an amidolytic assay].
    Camps J; Costa J; Pérez-Ayuso RM; Rimola A; Arroyo V; Gaya J
    Rev Esp Fisiol; 1983 Sep; 39(3):225-30. PubMed ID: 6197729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on kallikrein activity in diabetic patient with hypertension caused by nephropathy].
    Kunii N
    Nihon Jinzo Gakkai Shi; 1989 Jan; 31(1):39-48. PubMed ID: 2746999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous reactions to kallikrein, bradykinin and histamine in healthy subjects and in patients with urticaria.
    Juhlin L; Michaëlsson G
    Acta Derm Venereol; 1969; 49(1):26-36. PubMed ID: 4182090
    [No Abstract]   [Full Text] [Related]  

  • 11. On the role of the C1-esterase inhibitor in cold urticaria.
    Nilsson T; Bäck O
    Acta Derm Venereol; 1984; 64(3):197-202. PubMed ID: 6204479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kininogen-kallikrein-kinin system in plasma and saliva of patients with Sjögren's syndrome.
    Hernández CC; Donadi EA; Reis ML
    J Rheumatol; 1998 Dec; 25(12):2381-4. PubMed ID: 9858433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo effects of camostat mesilate on plasma kallikrein, plasma kininase II and renal kallikrein of man.
    Bönner G; Babst H; Kaufmann W
    Arzneimittelforschung; 1987 May; 37(5):535-7. PubMed ID: 3040018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The kallikrein-kinin system in operated and non-operated patients with acute pancreatitis.
    Hiltunen J; Kaukinen S; Pessi T; Ylitalo P
    Acta Chir Scand; 1985; 151(4):371-5. PubMed ID: 3849928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma IL-6 concentration correlates with clinical disease activity and serum C-reactive protein concentration in chronic urticaria patients.
    Kasperska-Zajac A; Sztylc J; Machura E; Jop G
    Clin Exp Allergy; 2011 Oct; 41(10):1386-91. PubMed ID: 21645137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cutaneous reactions to kallikrein, prostaglandin and thurfyl nicotinate in chronic urticaria and the effect of polyphloretin phosphate.
    Thune P; Ryan TJ; Powell SM; Ellis JR
    Acta Derm Venereol; 1976; 56(3):217-21. PubMed ID: 59506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Activity of the prekallikrein-kallikrein system and characteristics of its regulation in various allergies].
    Nenasheva NM; Dotsenko VL; Goriachkina LA; Iarovaia GA
    Vopr Med Khim; 1986; 32(5):106-11. PubMed ID: 3640571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct radioimmunoassay of rat urinary kallikrein: its application to the determination of active and inactive kallikrein concentration after HPLC analysis.
    Girolami JP; Bascands JL; Pecher C; Suc JM
    J Immunoassay; 1987; 8(1):115-30. PubMed ID: 3644825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of local radiotherapy on kallikrein activity in saliva secreted by parotid gland in patients with head and neck cancers.
    Czokało M; Silko J; Topczewska E
    Rocz Akad Med Bialymst; 1996; 41(2):441-51. PubMed ID: 9020557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antioxidant enzyme activity and malondialdehyde concentration in the plasma and erythrocytes of patients with urticaria induced by nonsteroidal anti-inflammatory drugs.
    Kasperska-Zajac A; Brzoza Z; Rogala B; Polaniak R; Birkner E
    J Investig Allergol Clin Immunol; 2008; 18(5):372-5. PubMed ID: 18973101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.